Comments
Shares of pharmaceutical major Cipla today fell over 2 per cent ahead of earnings.
The stock fell as much as 2.1 per cent.
The company will report December quarter earnings later in the day.
Net income is expected to miss estimates. It may come in at Rs 414 crore ($61 million) against the expected Rs 428 crore, according to Thomson Reuters Starmine SmartEstimates.
The stock had fallen 14.45 per cent this year, as of Tuesday’s close ($1 = 67.9250 Indian rupees)
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.